130
Participants
Start Date
October 12, 2004
Primary Completion Date
January 5, 2017
Study Completion Date
January 5, 2017
GM-CSF (Sargramostim)
250 mcg injection under the skin, three times a week for eight weeks.
Rituximab
375 mg/m\^2 administered intravenously once weekly for four weeks
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
Bayer
INDUSTRY
M.D. Anderson Cancer Center
OTHER